Interaction analyses were undertaken to assess statistically significant risk differences between subgroups.Īnalyses were performed with SAS Enterprise Guide version 8.2 (SAS Institute Inc). Differences in baseline characteristics between the groups were evaluated through absolute standardized differences (65 years COVID-19 vaccination SARS-CoV-2 infection status and use of outpatient COVID-19 antiviral treatment before admission) (eMethods in Supplement 1). The cohort was followed up until the first occurrence of death, 30 days after hospital admission, or March 2, 2023. We removed 143 participants hospitalized with both infections. Between October 1, 2022, and January 31, 2023, we enrolled all individuals with at least 1 hospital admission record between 2 days before and 10 days after a positive test result for SARS-CoV-2 or influenza and an admission diagnosis for COVID-19 or seasonal influenza. We used the electronic health databases of the US Department of Veterans Affairs (VA). Shared Decision Making and Communication.Scientific Discovery and the Future of Medicine.Health Care Economics, Insurance, Payment.Clinical Implications of Basic Neuroscience.Challenges in Clinical Electrocardiography.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |